Vaxxinity, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 75.22 million compared to USD 137.18 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 1.79 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0513 USD | +6.88% | -60.87% | -93.96% |
05-13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P Global BMI Index | CI |
05-13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-93.96% | 6.08M | |
+27.67% | 48.16B | |
-0.96% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.00% | 25.59B | |
-22.94% | 18.96B | |
+7.99% | 12.92B | |
+29.11% | 12.03B | |
-2.17% | 11.77B |
- Stock Market
- Equities
- VAXX Stock
- News Vaxxinity, Inc.
- Vaxxinity, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022